-
1
-
-
0142182561
-
Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism
-
DOI 10.1056/NEJMoa035451
-
Buller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349: 1695-1702. [CrossRef] [Medline] [Web of Science] (Pubitemid 37315006)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.18
, pp. 1695-1702
-
-
Buller, H.R.1
Davidson, B.L.2
Decousus, H.3
Gallus, A.4
Gent, M.5
Piovella, F.6
Prins, M.H.7
Raskob, G.8
Van Den B.-Segers, A.E.M.9
Cariou, R.10
Leeuwenkamp, O.11
Lensing, A.W.A.12
-
2
-
-
34047195192
-
-
GlaxoSmithKline. Research Triangle Park, NC: GlaxoSmithKline, October
-
GlaxoSmithKline. Arixtra (fondaparinux sodium) prescibing information. Research Triangle Park, NC: GlaxoSmithKline, October 2005.
-
(2005)
Arixtra (Fondaparinux Sodium) Prescibing Information
-
-
-
3
-
-
45949086068
-
Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
-
DOI 10.1378/chest.08-0689
-
Hirsh J, Bauer KA, Donati MB, et al. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Parenteral anticoagulants. Chest 2008; 133: 141S-159S. [CrossRef] [Medline] [Web of Science] (Pubitemid 351892966)
-
(2008)
Chest
, vol.133
, Issue.6 SUPPL. 6
-
-
Hirsh, J.1
Bauer, K.A.2
Donati, M.B.3
Gould, M.4
Samama, M.M.5
Weitz, J.I.6
-
4
-
-
0037069334
-
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers
-
DOI 10.1161/01.CIR.0000038501.87442.02
-
Bijsterveld NR, Moons AH, Boekholdt SM, et al. Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation 2002; 106: 2550-4. [Abstract/FREE Full text] (Pubitemid 35340690)
-
(2002)
Circulation
, vol.106
, Issue.20
, pp. 2550-2554
-
-
Bijsterveld, N.R.1
Moons, A.H.2
Boekholdt, S.M.3
Van Aken, B.E.4
Fennema, H.5
Peters, R.J.G.6
Meijers, J.C.M.7
Buller, H.R.8
Levi, M.9
-
5
-
-
34548361909
-
Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography
-
DOI 10.1097/MBC.0b013e328201c9a9, PII 0000172120070900000005
-
Young G, Yonekawa KE, Nakagawa PA, et al. Recombinant factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, aragatroban, and bivalirudin exvivo as measured by thromboelastography. Blood Coagul Fibrinolysis 2007; 18: 547-53. [CrossRef] [Medline] [Web of Science] (Pubitemid 47344302)
-
(2007)
Blood Coagulation and Fibrinolysis
, vol.18
, Issue.6
, pp. 547-553
-
-
Young, G.1
Yonekawa, K.E.2
Nakagawa, P.A.3
Blain, R.C.4
Lovejoy, A.E.5
Nugent, D.J.6
-
6
-
-
60449090517
-
Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aCCP and PCC
-
CrossRef
-
Desmurs-Clavel H, Huchon C, Chatard B, et al. Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aCCP and PCC. Thrombin Res 2009; 123: 796-8. [CrossRef]
-
(2009)
Thrombin Res
, vol.123
, pp. 796-798
-
-
Desmurs-Clavel, H.1
Huchon, C.2
Chatard, B.3
-
7
-
-
30944461398
-
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa
-
DOI 10.1001/jama.295.3.293
-
O'Connell KA, Wood JJ, Wise RP, et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006; 295: 293-8. [CrossRef] [Medline] [Web of Science] (Pubitemid 43112957)
-
(2006)
Journal of the American Medical Association
, vol.295
, Issue.3
, pp. 293-298
-
-
O'Connell, K.A.1
Wood, J.J.2
Wise, R.P.3
Lozier, J.N.4
Miles, B.M.5
-
8
-
-
34447527122
-
Retroperitoneal hematoma due to spontaneous lumbar artery rupture during fondaparinux treatment. Case report and a review of the literature
-
Medline
-
Fortina M, Carta S, Del Vecchio EO, et al. Retroperitoneal hematoma due to spontaneous lumbar artery rupture during fondaparinux treatment. Case report and a review of the literature. Acta Biomed 2007; 78: 46-50. [Medline]
-
(2007)
Acta Biomed
, vol.78
, pp. 46-50
-
-
Fortina, M.1
Carta, S.2
Del Vecchio, E.O.3
|